Neuromuscular Monitoring: TOF Ratio and Residual Block

Four visible twitches do not prove recovery from a non-depolarising neuromuscular block. The train-of-four count asks how many responses are present; the train-of-four ratio compares the fourth response with the first. Mixing up those measurements is an avoidable error in EDAIC pharmacology and in an emergence viva.

The ASA monitoring guideline recommends quantitative assessment at the adductor pollicis and confirmation of a ratio of at least 0.9 before extubation. That is one requirement in an assessment of recovery, not a complete extubation decision by itself.

First identify what the number actually measures

Imagine two displays. One says “TOF 4”. The other says “TOF ratio 0.62”. The first tells you that all four responses were detected. The second tells you that the last response was substantially smaller than the first. They can describe the same patient at the same moment.

The denominator matters. A ratio is not the fraction of the administered drug that has disappeared, the fraction of receptors occupied, or the patient's percentage of normal strength. Write T4/T1 before attaching an interpretation to it.

The Geneva research standards distinguish monitoring measurements and depths of block. For revision, their useful lesson is to describe the observed endpoint before naming a category. A label without its measurement can conceal an assumption.

Worked example: three different claims about recovery

This is an original examination exercise, not a clinical protocol. An adult has received a non-depolarising blocker during surgery. Near the end, four twitches are present. A quantitative monitor at the adductor pollicis displays 0.58. The candidate is offered three statements:

1. “There are four twitches, so there is no residual block.”
2. “The displayed ratio has not reached the recommended recovery threshold.”
3. “Once the ratio reaches the threshold, extubation must be safe.”

The second statement is the defensible one. The first substitutes a count for a ratio. The third turns a necessary neuromuscular assessment into a sufficient assessment of the whole patient.

Now change only one detail: the monitor displays 0.93. The numerical neuromuscular endpoint has been met if the measurement is technically valid, but the case has not supplied information about ventilation, oxygenation, consciousness, airway protection or the planned airway strategy. A good answer says what the new information resolves and what remains unknown.

That habit is useful well beyond this topic. When an exam gives a threshold, identify the question to which it belongs. Do not let it answer a different question by accident.

Measurement quality belongs in the answer

Before relying on a display, identify the monitoring site and technique and whether setup followed the device's requirements. A movement-based measurement can be affected by restricted movement. A response measured at a different muscle should not automatically be treated as interchangeable with one at the thumb.

Use a short verification sentence in a viva: “I would interpret a valid quantitative measurement from the appropriate site, rather than infer recovery from appearance alone.” This is more informative than reciting the threshold with no reference to how it was obtained.

Also keep chronology clear. “The ratio was satisfactory before transfer” and “the patient is satisfactory now” are different observations. A handover should make the measurement, timing and subsequent clinical state understandable, rather than reducing the whole emergence to “reversed”.

Reversal: connect mechanism to the measured endpoint

Learn the distinction between facilitating acetylcholine action and binding an appropriate neuromuscular blocker. Do not treat all antagonists as interchangeable across all blockers or depths. The ASA guideline links antagonist selection to the agent and measured depth; its recommendations do not make monitoring redundant after an antagonist is given.

For a revision card, put four prompts on the front: agent, depth, intervention, endpoint. On the back, explain why each is needed. “Which drug reverses this blocker?” is a narrower question and can produce a falsely complete answer.

The pharmacology topic map helps place this within Paper A. The clinical viva framework helps turn the same knowledge into an ordered spoken answer.

Test the distinction without memorising the example

Does a TOF count of four necessarily mean a ratio of one? No. Four responses can be present while the fourth remains smaller than the first. Count and ratio report different properties.

Does giving reversal prove that reversal is complete? No. It reports an intervention, not its measured result. State how the endpoint is confirmed.

Does a valid ratio of 0.95 exclude opioid-related hypoventilation? No. The ratio addresses neuromuscular transmission; it does not measure every determinant of breathing or wakefulness.

When using the AnesCORE question bank, mark whether an incorrect statement confused the measurement, the threshold or the clinical conclusion. Those three errors need different revision.

Sources

• ASA 2023: monitoring and antagonism of neuromuscular blockade
• Fuchs-Buder et al: 2023 Geneva revision of neuromuscular research standards

Prepared with AI assistance for examination revision; sources checked 6 November 2026. These original teaching examples are not official EDAIC questions. Not a patient-care protocol.